BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 418469)

  • 1. Dibenz[a,c]anthracene: a potent inhibitor of skin-tumor initiation by 7,12-dimethylbenz[a]anthracene.
    Slaga TJ; Viaje A; Buty SG; Bracken WM
    Res Commun Chem Pathol Pharmacol; 1978 Mar; 19(3):477-83. PubMed ID: 418469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the tumor-initiating ability of the potent carcinogen 7,12-dimethylbenz(a)anthracene by the weak tumor initiator 1,2,3,4-dibenzanthracene.
    Slaga TJ; Boutwell RK
    Cancer Res; 1977 Jan; 37(1):128-33. PubMed ID: 401469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticarcinogenic and cocarcinogenic effects of benzo[e]pyrene and dibenz[a,c]anthracene on skin tumor initiation by polycyclic hydrocarbons.
    DiGiovanni J; Rymer J; Slaga TJ; Boutwell RK
    Carcinogenesis; 1982; 3(4):371-5. PubMed ID: 6284398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of 7,12-dimethylbenz(alpha)anthracene metabolites on its capacity to induce skin tumors in mice].
    Lopp LKh; Belitskiĭ GA
    Vopr Onkol; 1975; 21(10):50-5. PubMed ID: 810968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent binding of 7,12-dimethylbenz(a)anthracene and 10-fluoro-7,12-dimethylbenz(a)anthracene to mouse epidermal DNA and its relationship to tumor-initiating activity.
    DiGiovanni J; Fisher EP; Aalfs KK; Prichett WP
    Cancer Res; 1985 Feb; 45(2):591-7. PubMed ID: 3917851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent tumor-initiating activity of the 3,4-dihydrodiol of 7,12-dimethylbenz(a)anthracene in mouse skin.
    Slaga TJ; Gleason GL; DiGiovanni J; Sukumaran KB; Harvey RG
    Cancer Res; 1979 Jun; 39(6 Pt 1):1934-6. PubMed ID: 109189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of antioxidants on skin tumor initiation and aryl hydrocarbon hydroxylase.
    Slaga TJ; Bracken WM
    Cancer Res; 1977 Jun; 37(6):1631-5. PubMed ID: 404033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between formation of a specific hydrocarbon-deoxyribonucleoside adduct and tumor-initiating activity of 7,12-dimethylbenz(a)anthracene and its 9- and 10-monofluoroderivatives in mice.
    DiGiovanni J; Sawyer TW; Fisher EP
    Cancer Res; 1986 Sep; 46(9):4336-41. PubMed ID: 3089589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of weak or non-carcinogenic polycyclic hydrocarbons on 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene skin tumor-initiation.
    Slaga TJ; Jecker L; Bracken WM; Weeks CE
    Cancer Lett; 1979 Jun; 7(1):51-9. PubMed ID: 110441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution, covalent binding, and DNA adduct formation of 7,12-dimethylbenz(a)anthracene in SENCAR and BALB/c mice following topical and oral administration.
    Morse MA; Baird WM; Carlson GP
    Cancer Res; 1987 Sep; 47(17):4571-5. PubMed ID: 2441852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse skin tumor-initiating activity of 5-, 7-, and 12-methyl- and fluorine-substituted benz[a]anthracenes.
    Wood AW; Levin W; Chang RL; Conney AH; Slaga TJ; O'Malley RF; Newman MS; Buhler DR; Jerina DM
    J Natl Cancer Inst; 1982 Sep; 69(3):725-8. PubMed ID: 6810009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
    Iversen OH
    APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.
    Verma AK; Garcia CT; Ashendel CL; Boutwell RK
    Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzo(e)pyrene-induced alterations in the binding of benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene to DNA in Sencar mouse epidermis.
    Smolarek TA; Baird WM; Fisher EP; DiGiovanni J
    Cancer Res; 1987 Jul; 47(14):3701-6. PubMed ID: 3109730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of 7-hydroxymethyl-12-methylbenz(a)anthracene-DNA adducts from 7,12-dimethylbenz(a)anthracene in mouse epidermis.
    DiGiovanni J; Nebzydoski AP; Decina PC
    Cancer Res; 1983 Sep; 43(9):4221-6. PubMed ID: 6409399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The early effects of a single application of acetone and various doses of 7,12-dimethylbenz(alpha)anthracene on CD-1 and hairless mouse epidermis. A cell kinetic study of so-called initiation and complete carcinogenesis (initiation plus promotion) in chemical skin tumor induction.
    Iversen OH; Ljunggren S; Olsen WM
    APMIS Suppl; 1988; 2():7-80. PubMed ID: 3140844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticarcinogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene tumor initiation and its relationship to DNA binding.
    Cohen GM; Bracken WM; Iyer RP; Berry DL; Selkirk JK; Slaga TJ
    Cancer Res; 1979 Oct; 39(10):4027-33. PubMed ID: 113085
    [No Abstract]   [Full Text] [Related]  

  • 18. Modulation of carcinogen metabolism and DNA interaction by calcium glucarate in mouse skin.
    Gupta KP; Singh J
    Toxicol Sci; 2004 May; 79(1):47-55. PubMed ID: 14976333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene.
    Scribner JD; Scribner NK; McKnight B; Mottet NK
    Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of deoxycholic acid on 7,12-dimethylbenz(a)anthracene-induced, two-stage mouse skin carcinogenesis.
    Glauert HP; Bennink MR
    Res Commun Chem Pathol Pharmacol; 1978 Dec; 22(3):609-12. PubMed ID: 104372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.